Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B [PDF]
William G. Morice +3 more
openalex +1 more source
The combination of acute leukemia and pregnancy is infrequent. It is estimated to occur in less than 1 in 75,000 pregnancies. Maternal and fetal outcomes have improved substantially in recent years.
V. Karagiannis +6 more
doaj +1 more source
Quantitative PCR for HTLV‐1 provirus in adult T‐cell leukemia/lymphoma using paraffin tumor sections [PDF]
Junki Kato +9 more
openalex +1 more source
Background Acute myeloid leukaemia (AML) with 17p abnormalities (abn(17p)) carries a very poor prognosis due to high refractoriness to conventional chemotherapy, and allogeneic stem cell transplantation (allo-SCT) appears as the only potential curative ...
Xavier Poiré +15 more
doaj +1 more source
Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections Using a Highly Effective CD103 Rabbit Monoclonal Antibody [PDF]
Elizabeth A. Morgan +3 more
openalex +1 more source
Immunohistochemical Detection of Hairy Cell Leukemia in Paraffin Sections: The Role of Pax5 and CD103 Double Staining to Improve Specificity and Sensitivity [PDF]
Igor B. Rozenvald +3 more
openalex +1 more source
Targeting survivin in leukemia
Survivin, a member of the inhibitors of apoptosis family of proteins, is one of the most frequently upregulated transcripts in solid tumors and hematopoietic malignancies.
Bing Z. Carter, Michael Andreeff
doaj +2 more sources
Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist’s Point of View [PDF]
Houssam Rebahi +2 more
openalex +1 more source
Patients with cytogenetically normal acute myeloid leukemia (CN-AML) may harbor prognostically relevant gene mutations and thus be categorized into one of the three 2022 European LeukemiaNet (ELN) genetic-risk groups.
Kellie J. Archer +13 more
doaj +1 more source
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]
Amer M Zeidan,1,* Courtney DiNardo2,* 1Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA; 2Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA*These authors contributed equally to this ...
Zeidan AM, DiNardo C
doaj

